After a big rally on Wall Street, it's somewhat understandable that investors would come into the new week ready for a breather. Stock index futures suggested that might be the case, with most major benchmarks indicating modest declines of around a third of a percent in premarket trading.

However, there was considerable activity in the biopharmaceutical stock space. Dice Therapeutics (NASDAQ: DICE) made a huge move higher on merger news, while Sanofi (NASDAQ: SNY) scored a significant victory that has shareholders feeling better about the company's prospects. Read on to learn more about both of these companies and the impact they're having on the biopharma space more broadly.

Shares of Dice Therapeutics jumped 38% in premarket trading on Tuesday morning. The South San Francisco-based biotech company got an acquisition offer from a leading company in the pharmaceutical space, and the price was too good to pass up.

Continue reading

Source Fool.com